42 biology uni jobs at University of Texas MD Anderson Cancer Center in United States
Sort by
Refine Your Search
-
The Group Leader, Drug Discovery Biology is responsible for managing and supervising aspects of drug discovery biology, including target identification and validation through advancement of drug
-
approach combines innovative cancer genetics, disruptive technologies, deep mechanistic biology, disease modeling, and pharmacology to accelerate the translation of novel discoveries into definitive clinical
-
developed the infrastructure, platforms, and capabilities to enable transformative research. TRACTION's approach combines innovative cancer genetics, disruptive technologies, deep mechanistic biology, disease
-
Senior Administrative Assistant - Hematopoietic Biology & Malignancy The University of Texas MD Anderson Cancer Center in Houston is one of the world's most respected centers focused on cancer
-
Scientist will lead various basic and translational research projects utilizing functional genomics and systems biology techniques as well as traditional cell biology and immunobiology tools including tumor
-
. organoids in matrigel). 2.Utilize common molecular and cell biology skills including immunohistochemistry/immunofluorescence, RNAscope, single cell sequencing, etc., to characterize and biobank models. 3.In
-
Scientist is to plan, direct, organize, and participates in scientific research projects in cancer biology of gastro-esophageal cancers. Key Functions Plans, organizes, coordinates, directs and participates
-
creativity and novel approaches to solving scientific problems is preferred. EDUATION Required: Bachelor's degree in Biology, Biochemistry, Molecular Biology, Cell Biology, Enzymology, Pharmacology, Chemistry
-
and physicians for which MD Anderson is known. TRACTION's approach combines large scale data science, innovative cancer genetics, disruptive technologies, deep mechanistic biology, disease modeling, and
-
Anderson is known. TRACTION's approach combines large scale data science, innovative cancer genetics, disruptive technologies, deep mechanistic biology, disease modeling, and pharmacology to accelerate